JP2012511023A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511023A5 JP2012511023A5 JP2011539755A JP2011539755A JP2012511023A5 JP 2012511023 A5 JP2012511023 A5 JP 2012511023A5 JP 2011539755 A JP2011539755 A JP 2011539755A JP 2011539755 A JP2011539755 A JP 2011539755A JP 2012511023 A5 JP2012511023 A5 JP 2012511023A5
- Authority
- JP
- Japan
- Prior art keywords
- integer
- compound
- pharmaceutically acceptable
- tissue
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12022608P | 2008-12-05 | 2008-12-05 | |
| US61/120,226 | 2008-12-05 | ||
| US18034109P | 2009-05-21 | 2009-05-21 | |
| US61/180,341 | 2009-05-21 | ||
| PCT/US2009/066836 WO2010065902A2 (en) | 2008-12-05 | 2009-12-04 | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012511023A JP2012511023A (ja) | 2012-05-17 |
| JP2012511023A5 true JP2012511023A5 (enExample) | 2012-11-01 |
| JP5220203B2 JP5220203B2 (ja) | 2013-06-26 |
Family
ID=42076951
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539755A Active JP5220203B2 (ja) | 2008-12-05 | 2009-12-04 | テクネチウム−及びレニウム−ビス（ヘテロアリール）錯体及びｐｓｍａを阻害するその使用方法 |
| JP2011539752A Pending JP2012511022A (ja) | 2008-12-05 | 2009-12-04 | テクネチウム及びレニウム−ビス（ヘテロアリール）錯体及びその使用方法 |
| JP2011539757A Ceased JP2012511024A (ja) | 2008-12-05 | 2009-12-04 | 癌の治療及び撮像用のｃａ−ｉｘ特異性放射性医薬品 |
| JP2014145241A Active JP5856247B2 (ja) | 2008-12-05 | 2014-07-15 | テクネチウム及びレニウム−ビス（ヘテロアリール）錯体及びその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539752A Pending JP2012511022A (ja) | 2008-12-05 | 2009-12-04 | テクネチウム及びレニウム−ビス（ヘテロアリール）錯体及びその使用方法 |
| JP2011539757A Ceased JP2012511024A (ja) | 2008-12-05 | 2009-12-04 | 癌の治療及び撮像用のｃａ−ｉｘ特異性放射性医薬品 |
| JP2014145241A Active JP5856247B2 (ja) | 2008-12-05 | 2014-07-15 | テクネチウム及びレニウム−ビス（ヘテロアリール）錯体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8211401B2 (enExample) |
| EP (4) | EP2373622A2 (enExample) |
| JP (4) | JP5220203B2 (enExample) |
| CN (3) | CN102272101A (enExample) |
| AU (3) | AU2009322167B2 (enExample) |
| BR (3) | BRPI0922839A2 (enExample) |
| CA (3) | CA2745955C (enExample) |
| ES (2) | ES2574514T3 (enExample) |
| HU (2) | HUE029940T2 (enExample) |
| PL (2) | PL2389361T3 (enExample) |
| RU (3) | RU2532912C2 (enExample) |
| TW (3) | TW201034689A (enExample) |
| WO (1) | WO2010065902A2 (enExample) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9193763B2 (en) | 2007-08-17 | 2015-11-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| US8855387B2 (en) | 2007-12-28 | 2014-10-07 | Exini Diagnostics Ab | System for detecting bone cancer metastases |
| AU2009204133B2 (en) | 2008-01-09 | 2014-04-10 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of carbonic anhydrase IX |
| US8562945B2 (en) | 2008-01-09 | 2013-10-22 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| WO2010065906A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| BRPI0922839A2 (pt) * | 2008-12-05 | 2019-09-03 | Molecular Insight Pharmaceuticals, Inc. | radiofarmacêuticos específicos de ca-ix para tratamento e imageamento de câncer. |
| BR112012000209B8 (pt) | 2009-06-15 | 2021-07-27 | Molecular Insight Pharm Inc | heterodímeros de ácido glutâmico e seus processos de preparação |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| US9687572B2 (en) | 2010-12-06 | 2017-06-27 | Molecular Insight Pharmaceuticals, Inc. | PSMA-targeted dendrimers |
| PL2739316T3 (pl) * | 2011-08-05 | 2019-09-30 | Molecular Insight Pharmaceuticals, Inc. | Radioznakowane inhibitory antygenu błonowego specyficznego dla prostaty |
| US10011632B2 (en) | 2011-08-22 | 2018-07-03 | Siemens Medical Solutions Usa, Inc. | PSMA imaging agents |
| CN107382890B (zh) | 2011-11-30 | 2021-01-29 | 约翰霍普金斯大学 | 前列腺特异性膜抗原(psma)的同源多价抑制剂和异源多价抑制剂以及其用途 |
| EP2800471A4 (en) | 2012-01-06 | 2015-11-04 | Molecular Insight Pharm Inc | METAL COMPLEX OF POLY (CARBOXYL) AMINE CONTAINING LIGANDS HAVING AFFINITY FOR CARBON IX ANHYDRASE |
| FR2989085A1 (fr) * | 2012-04-05 | 2013-10-11 | Commissariat Energie Atomique | Radiotraceurs, procedes de preparation et applications |
| AU2013344778C1 (en) | 2012-11-15 | 2024-06-27 | Endocyte, Inc. | Conjugates for treating diseases caused by PSMA expressing cells |
| CA2897437C (en) * | 2013-01-14 | 2021-12-14 | Molecular Insight Pharmaceuticals, Inc. | Triazine based radiopharmaceuticals and radioimaging agents |
| AU2014257164B2 (en) * | 2013-04-22 | 2018-10-11 | Abbvie Inc. | Thiazoles and uses thereof |
| EP3057620A4 (en) * | 2013-10-18 | 2017-05-24 | Molecular Insight Pharmaceuticals, Inc. | Methods of using spect/ct analysis for staging cancer |
| EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| CN105849568B (zh) | 2013-11-14 | 2018-05-04 | 恩多塞特公司 | 用于正电子发射断层术的化合物 |
| EP2993171A1 (en) * | 2014-09-04 | 2016-03-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the production of 18F-labeled PSMA-specific PET-tracers |
| US9956305B2 (en) | 2014-09-08 | 2018-05-01 | Molecular Insight Pharmaceuticals, Inc. | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| SI3356385T1 (sl) | 2015-09-30 | 2021-04-30 | Deutsches Krebsforschungszentrum | 18F-označeni inhibitorji prostatnih membranskih antigenov (PSMA) in njihova uporaba kot slikovno prikazna sredstva za rak prostate |
| KR101639599B1 (ko) * | 2015-11-09 | 2016-07-14 | 서울대학교산학협력단 | 펩타이드 싸이오우레아 유도체, 이를 포함하는 방사성 동위원소 표지 화합물 및 이를 유효 성분으로 함유하는 전립선암 치료 또는 진단용 약학적 조성물 |
| EP3192810A1 (en) * | 2016-01-14 | 2017-07-19 | Deutsches Krebsforschungszentrum | Psma binding antibody and uses thereof |
| CN105510511B (zh) * | 2016-01-23 | 2017-04-12 | 河北科技大学 | 一种2‑氨基丁醇对映异构体的hplc分离检测方法 |
| RS62274B1 (sr) * | 2016-03-22 | 2021-09-30 | Univ Johns Hopkins | Sredstva sa visokim afinitetom za ciljano dejstvo na membranski antigen specifičan za prostatu za endoradioterapiju kancera prostate |
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| AU2017281364B2 (en) | 2016-06-23 | 2023-06-22 | Cornell University | Double targeted constructs to affect tumor kill |
| US10340046B2 (en) | 2016-10-27 | 2019-07-02 | Progenics Pharmaceuticals, Inc. | Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications |
| KR102724812B1 (ko) | 2017-04-05 | 2024-11-01 | 코넬 유니버시티 | 영상화 및 항종양 치료요법에 유용한 조정 가능한 약동학을 갖는 삼작용성 작제물 |
| WO2018222778A1 (en) * | 2017-05-30 | 2018-12-06 | The Johns Hopkins University | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer |
| WO2019115684A1 (en) | 2017-12-13 | 2019-06-20 | Sciencons AS | Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide |
| EP3738097B1 (en) | 2018-01-08 | 2025-03-05 | Progenics Pharmaceuticals, Inc. | System and method for rapid neural network-based image segmentation |
| US10973486B2 (en) | 2018-01-08 | 2021-04-13 | Progenics Pharmaceuticals, Inc. | Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination |
| US12602772B2 (en) | 2018-01-08 | 2026-04-14 | Progenics Pharmaceuticals, Inc. | Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination |
| CA3090495A1 (en) * | 2018-02-06 | 2019-08-15 | The Johns Hopkins University | Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy |
| RU2692126C1 (ru) * | 2018-02-13 | 2019-06-21 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Способ получения производного мочевины с хелатным центром, тропного к простат-специфичному мембранному антигену для связывания технеция-99м/рения для диагностики/лечения рака предстательной железы |
| KR20210003135A (ko) | 2018-04-17 | 2021-01-11 | 엔도사이트, 인코포레이티드 | 암의 치료 방법 |
| US20210276971A1 (en) * | 2018-06-20 | 2021-09-09 | The Research Foundation For The State University Of New York | Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same |
| KR20210052435A (ko) * | 2018-08-30 | 2021-05-10 | 니혼 메디피직스 가부시키가이샤 | 방사성 이미다조티아디아졸 유도체 화합물 |
| CN113272859B (zh) | 2019-01-07 | 2025-04-04 | 西尼诊断公司 | 用于平台中立性全身图像分段的系统及方法 |
| US11948283B2 (en) | 2019-04-24 | 2024-04-02 | Progenics Pharmaceuticals, Inc. | Systems and methods for interactive adjustment of intensity windowing in nuclear medicine images |
| TWI872062B (zh) | 2019-04-24 | 2025-02-11 | 美商普吉尼製藥公司 | 用於偵測轉移之骨掃描影像之自動及互動式分析系統、裝置及方法 |
| JP7604397B2 (ja) | 2019-05-20 | 2024-12-23 | エンドサイト・インコーポレイテッド | Ｐｓｍａコンジュゲートの調製方法 |
| US11900597B2 (en) | 2019-09-27 | 2024-02-13 | Progenics Pharmaceuticals, Inc. | Systems and methods for artificial intelligence-based image analysis for cancer assessment |
| US12417533B2 (en) | 2019-09-27 | 2025-09-16 | Progenics Pharmaceuticals, Inc. | Systems and methods for artificial intelligence-based image analysis for cancer assessment |
| US11544407B1 (en) | 2019-09-27 | 2023-01-03 | Progenics Pharmaceuticals, Inc. | Systems and methods for secure cloud-based medical image upload and processing |
| US11564621B2 (en) | 2019-09-27 | 2023-01-31 | Progenies Pharmacenticals, Inc. | Systems and methods for artificial intelligence-based image analysis for cancer assessment |
| US11321844B2 (en) | 2020-04-23 | 2022-05-03 | Exini Diagnostics Ab | Systems and methods for deep-learning-based segmentation of composite images |
| US11386988B2 (en) | 2020-04-23 | 2022-07-12 | Exini Diagnostics Ab | Systems and methods for deep-learning-based segmentation of composite images |
| US11721428B2 (en) | 2020-07-06 | 2023-08-08 | Exini Diagnostics Ab | Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions |
| KR20230050319A (ko) | 2020-07-06 | 2023-04-14 | 엑시니 다이어그노스틱스 에이비 | 병변들의 검출 및 특성화를 위한 인공 지능 기반 영상 분석을 위한 시스템들 및 방법들 |
| EP4326246A4 (en) * | 2021-04-23 | 2026-04-15 | Wisconsin Alumni Res Found | PSMA-TARGETING LIGANDS WITH OPTIMAL IMAGING AND THERAPY PROPERTIES |
| AU2022361659A1 (en) | 2021-10-08 | 2024-03-21 | Exini Diagnostics Ab | Systems and methods for automated identification and classification of lesions in local lymph and distant metastases |
| JP2024547009A (ja) * | 2021-12-24 | 2024-12-26 | エルジー エナジー ソリューション リミテッド | 正極活物質、これを含む正極およびリチウム二次電池 |
| CN119325617A (zh) | 2022-06-08 | 2025-01-17 | 普罗热尼奇制药公司 | 评估疾病负荷和进展的系统和方法 |
| US20240285248A1 (en) | 2023-02-13 | 2024-08-29 | Progenics Pharmaceuticals, Inc. | Systems and methods for predicting biochemical progression free survival in prostate cancer patients |
| US20240354940A1 (en) | 2023-04-07 | 2024-10-24 | Progenics Pharmaceuticals, Inc. | Systems and methods for facilitating lesion inspection and analysis |
| WO2025072177A1 (en) | 2023-09-25 | 2025-04-03 | Progenics Pharmaceuticals, Inc. | Systems and methods for automated cancer staging and risk prediction |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
| US2730456A (en) * | 1953-06-30 | 1956-01-10 | Ncr Co | Manifold record material |
| US2730457A (en) * | 1953-06-30 | 1956-01-10 | Ncr Co | Pressure responsive record materials |
| US3625214A (en) * | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
| US4272398A (en) * | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
| US4906474A (en) * | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
| JPS6131056A (ja) * | 1984-07-25 | 1986-02-13 | K Baiorojikaru Sci Lab:Kk | ホイッピングクリームの製造方法 |
| WO1988001213A1 (en) * | 1986-08-18 | 1988-02-25 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents |
| JP3051497B2 (ja) * | 1991-05-17 | 2000-06-12 | 株式会社第一ラジオアイソトープ研究所 | スルファニルアミド誘導体のテクネチウム錯体をもちいる放射性診断剤 |
| US6359120B1 (en) * | 1991-10-29 | 2002-03-19 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| DK0570575T3 (da) * | 1991-12-10 | 1998-08-24 | Dow Chemical Co | Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf |
| ES2200617B1 (es) * | 2001-01-19 | 2005-05-01 | Almirall Prodesfarma, S.A. | Derivados de urea como antagonistas de integrinas alfa 4. |
| WO2002094261A1 (fr) * | 2001-05-24 | 2002-11-28 | Kureha Chemical Industry Company, Limited | Medicaments antagonistes de cxcr4 comprenant un compose contenant de l'azote |
| DE10127581A1 (de) * | 2001-05-29 | 2003-01-02 | Schering Ag | CDK inhibitorische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel |
| DE10135355C1 (de) | 2001-07-20 | 2003-04-17 | Schering Ag | Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie |
| US20030100594A1 (en) | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
| WO2003053932A1 (en) * | 2001-12-21 | 2003-07-03 | Tohru Koike | Zinc complexes capable of scavenging substances bearing anionic substituents |
| CA2372731A1 (en) * | 2002-02-22 | 2003-08-22 | Claudiu T. Supuran | Oligo-amine/oligo-carboxy sulfonamides |
| WO2003077727A2 (en) * | 2002-03-11 | 2003-09-25 | Biostream, Inc. | Technetium-dipyridine complexes, and methods of use thereof |
| DE10231799B4 (de) * | 2002-07-10 | 2006-10-05 | Schering Ag | Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben |
| AU2003261974A1 (en) * | 2002-09-11 | 2004-04-30 | Kureha Chemical Industry Company, Limited | Amine compounds and use thereof |
| US7833734B2 (en) * | 2002-11-26 | 2010-11-16 | Institute Of Virology Of The Slovak Academy Of Sciences | CA IX-specific inhibitors |
| AU2003295950B2 (en) | 2002-11-26 | 2007-06-28 | Institute Of Virology | CA IX-specific inhibitors |
| CA2520259A1 (en) * | 2003-04-11 | 2004-10-28 | Anormed Inc. | Cxcr4 chemokine receptor binding compounds |
| CA2547863A1 (en) | 2003-12-12 | 2005-06-23 | Oy Juvantia Pharma Ltd | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy |
| EP1718342A4 (en) * | 2004-02-12 | 2009-07-22 | Molecular Insight Pharm Inc | TECHNETIUM AND RHENIUM-BIS (HETEROARYL) COMPLEXES AND APPLICATION METHODS |
| JP3977411B2 (ja) * | 2004-03-10 | 2007-09-19 | 株式会社クレハ | アミン系塩基性化合物とその用途 |
| WO2006080993A1 (en) | 2004-12-08 | 2006-08-03 | Purdue Research Foundation | Novel cationic metal complex radiopharmaceuticals |
| WO2006137092A1 (en) * | 2005-06-23 | 2006-12-28 | Supuran Claudiu T | Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as theapeutic and diagnostic agents |
| FR2890657B1 (fr) * | 2005-09-15 | 2007-11-09 | Commissariat Energie Atomique | Procede d'obtention de complexes de lanthanides hautement luminescents. |
| EP1961744B1 (en) | 2005-11-18 | 2013-04-17 | Ono Pharmaceutical Co., Ltd. | Basic group-containing compound and use thereof |
| BRPI0621307A2 (pt) | 2006-02-06 | 2011-12-06 | Ciba Holding Inc. | uso de compostos de complexo metálico como catalisadores de oxidação |
| ZA200810739B (en) | 2006-06-20 | 2010-03-31 | Ishihara Sangyo Kaisha | Pesticide containing novel pyridyl-methanamine derivative or its salt |
| EP2055705A4 (en) * | 2006-07-31 | 2014-08-20 | Ono Pharmaceutical Co | COMPOUND WITH A CYCLIC GROUP BOUND BY A SPIRO BINDING THEREOF AND APPLY THEREOF |
| JP2010502646A (ja) | 2006-08-29 | 2010-01-28 | バイオストリーム セラピューティクス インコーポレーティッド | ペプチダーゼ結合部分と結合しペプチダーゼ発現組織及び器官をイメージングする放射性イメージング部分 |
| CA2669127C (en) * | 2006-11-08 | 2016-09-13 | Molecular Insight Pharmaceuticals, Inc. | Heterodimers of glutamic acid |
| CA2676413A1 (en) * | 2007-01-19 | 2008-07-31 | Mallinckrodt Inc. | Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| WO2008098056A2 (en) * | 2007-02-06 | 2008-08-14 | Epix Pharmaceuticals, Inc. | High relaxivity chelates |
| WO2009076434A1 (en) | 2007-12-12 | 2009-06-18 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of integrin vla-4 |
| US8562945B2 (en) * | 2008-01-09 | 2013-10-22 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| AU2009204133B2 (en) * | 2008-01-09 | 2014-04-10 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of carbonic anhydrase IX |
| EP2349995A1 (en) * | 2008-09-25 | 2011-08-03 | Molecular Insight Pharmaceuticals, Inc. | Selective seprase inhibitors |
| BRPI0922839A2 (pt) * | 2008-12-05 | 2019-09-03 | Molecular Insight Pharmaceuticals, Inc. | radiofarmacêuticos específicos de ca-ix para tratamento e imageamento de câncer. |
| WO2010065906A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
-
2009
- 2009-12-04 BR BRPI0922839-0A patent/BRPI0922839A2/pt not_active IP Right Cessation
- 2009-12-04 EP EP09775430A patent/EP2373622A2/en not_active Withdrawn
- 2009-12-04 ES ES13195617.9T patent/ES2574514T3/es active Active
- 2009-12-04 CN CN2009801538771A patent/CN102272101A/zh active Pending
- 2009-12-04 WO PCT/US2009/066836 patent/WO2010065902A2/en not_active Ceased
- 2009-12-04 TW TW098141532A patent/TW201034689A/zh unknown
- 2009-12-04 EP EP09775429.5A patent/EP2389361B1/en active Active
- 2009-12-04 AU AU2009322167A patent/AU2009322167B2/en active Active
- 2009-12-04 US US12/631,337 patent/US8211401B2/en active Active
- 2009-12-04 JP JP2011539755A patent/JP5220203B2/ja active Active
- 2009-12-04 TW TW098141536A patent/TW201034690A/zh unknown
- 2009-12-04 CA CA2745955A patent/CA2745955C/en active Active
- 2009-12-04 CA CA2745958A patent/CA2745958A1/en not_active Abandoned
- 2009-12-04 RU RU2011127468/04A patent/RU2532912C2/ru active
- 2009-12-04 BR BRPI0922779A patent/BRPI0922779A8/pt active Search and Examination
- 2009-12-04 HU HUE13195617A patent/HUE029940T2/en unknown
- 2009-12-04 CN CN2009801538786A patent/CN102272102A/zh active Pending
- 2009-12-04 AU AU2009322164A patent/AU2009322164B2/en active Active
- 2009-12-04 PL PL09775429T patent/PL2389361T3/pl unknown
- 2009-12-04 HU HUE09775429A patent/HUE030681T2/en unknown
- 2009-12-04 EP EP09765209A patent/EP2373621A2/en not_active Withdrawn
- 2009-12-04 CN CN200980153722.8A patent/CN102272100B/zh active Active
- 2009-12-04 BR BRPI0922840A patent/BRPI0922840A2/pt active IP Right Grant
- 2009-12-04 JP JP2011539752A patent/JP2012511022A/ja active Pending
- 2009-12-04 RU RU2011127467/04A patent/RU2539565C2/ru not_active IP Right Cessation
- 2009-12-04 TW TW098141540A patent/TW201034691A/zh unknown
- 2009-12-04 CA CA2745918A patent/CA2745918C/en active Active
- 2009-12-04 RU RU2011127462/04A patent/RU2539584C2/ru active
- 2009-12-04 ES ES09775429.5T patent/ES2595128T3/es active Active
- 2009-12-04 PL PL13195617.9T patent/PL2706057T3/pl unknown
- 2009-12-04 JP JP2011539757A patent/JP2012511024A/ja not_active Ceased
- 2009-12-04 AU AU2009322171A patent/AU2009322171A1/en not_active Abandoned
- 2009-12-04 EP EP14155382.6A patent/EP2759535A1/en not_active Withdrawn
-
2014
- 2014-07-15 JP JP2014145241A patent/JP5856247B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011127468A (ru) | Технецкий- и рений-бис(гетероарильные) комплексы и методы их применения для ингибирования psma | |
| EP4473980A3 (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers | |
| RU2011127467A (ru) | Са-ix специфические радиофармпрепараты для лечения и визуализации злокачественных опухолей | |
| JP2021503490A5 (enExample) | ||
| ES2636618T3 (es) | Compuestos peptídicos a base de urea útiles para la detección entre otros de cáncer de próstata | |
| JP2022159345A5 (enExample) | ||
| JP2013507423A5 (enExample) | ||
| JP2774940B2 (ja) | エーテル置換イソニトリルおよびその製法 | |
| JP2016193934A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2011529919A5 (enExample) | ||
| JP2013544276A5 (enExample) | ||
| JP6661010B2 (ja) | ペプチドチオ尿素誘導体、これを含有する放射線同位体標識化合物、およびこれを活性成分として含有する前立腺癌を処置または診断するための医薬組成物 | |
| JP2014505017A5 (enExample) | ||
| JP2013519632A5 (enExample) | ||
| JP2017518971A (ja) | Ｐｓｍａを標的としたイメージング及び放射線治療のための金属／放射性金属標識ｐｓｍａ阻害剤 | |
| JP2008505157A5 (enExample) | ||
| JP2006514689A5 (ja) | １−オキソ−２−（２，６−ジオキソピペリジン−３−イル）−４−メチルイソインドリンを含む脳腫瘍の治療及び管理のための医薬組成物 | |
| JP2006528205A5 (enExample) | ||
| RU2008106058A (ru) | Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона | |
| JP2012525393A5 (enExample) | ||
| JP2547514B2 (ja) | プロピレンアミンオキシム | |
| JP2013538849A5 (enExample) | ||
| JP2012532883A5 (enExample) | ||
| JP2016521275A5 (enExample) |